Nath Bio-Genes (India) Limited
NSE:NATHBIOGEN.NS
217.25 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 774.096 | 379.952 | 41.68 | 292.111 | 219.799 | 213.793 | 446.583 | 58.47 | 12.245 | 15.721 | 22.135 | 24.801 | 32.909 |
| Short Term Investments
| 1,629.393 | 1,709.287 | 0.152 | -0 | 215.001 | 200.001 | -1.87 | 0 | 49.94 | 49.94 | 49.94 | 116.484 | -15 |
| Cash and Short Term Investments
| 774.096 | 2,089.239 | 41.68 | 292.111 | 219.799 | 213.793 | 446.583 | 58.47 | 62.185 | 65.661 | 72.075 | 24.801 | 32.909 |
| Net Receivables
| 943.086 | 1,033.625 | 2,456.594 | 2,683.818 | 1,100.178 | 2,304.44 | 1,860.91 | 1,049.09 | 771.589 | 716.657 | 612.811 | 375.078 | 259.075 |
| Inventory
| 2,303.091 | 2,078.466 | 2,203.427 | 2,262.999 | 2,043.081 | 1,553.562 | 1,234.572 | 1,301.509 | 1,407.398 | 1,170.349 | 885.684 | 771.745 | 657.557 |
| Other Current Assets
| 1,696.373 | 6.988 | 0.002 | 0 | 2,508.733 | 0 | 0 | 10.306 | 11.531 | 24.644 | 21.943 | 25.871 | 12.66 |
| Total Current Assets
| 5,716.646 | 5,208.318 | 4,701.703 | 5,238.928 | 4,771.613 | 4,071.795 | 3,542.065 | 2,419.375 | 2,252.703 | 1,977.312 | 1,592.512 | 1,197.496 | 962.201 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 2,406.476 | 2,339.595 | 2,328.519 | 2,332.961 | 2,308.524 | 2,281.043 | 2,069.368 | 415.538 | 284.329 | 78.538 | 82.411 | 259.818 | 58.681 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 88.118 | 104.174 | 120.263 | 136.188 | 151.65 | 36 | 40 | 0 | 20.245 | 49.416 | 82.941 | 116.465 | 0 |
| Goodwill and Intangible Assets
| 88.118 | 104.174 | 120.263 | 136.188 | 151.65 | 36 | 40 | -49.968 | 20.245 | 49.416 | 82.941 | 116.465 | 149.989 |
| Long Term Investments
| 169.479 | 50.482 | 50.48 | 50.478 | 49.975 | 49.973 | 51.841 | 49.968 | -49.914 | -49.917 | -49.919 | -116.465 | 20.056 |
| Tax Assets
| 0 | 0 | 218.119 | 136.545 | 6.937 | 7.241 | 8.62 | 8.541 | 8.686 | 10.559 | 9.35 | 9.03 | 8.624 |
| Other Non-Current Assets
| 421.587 | 225.401 | -0.002 | -0 | 10.757 | 14.582 | 0.155 | 50.089 | 150.952 | 195.526 | 181.988 | 116.484 | -0 |
| Total Non-Current Assets
| 3,085.66 | 2,719.652 | 2,717.379 | 2,656.172 | 2,527.844 | 2,388.839 | 2,169.984 | 474.168 | 414.298 | 284.122 | 306.771 | 385.332 | 237.351 |
| Total Assets
| 8,802.306 | 7,927.97 | 7,419.082 | 7,895.1 | 7,299.457 | 6,460.634 | 5,712.049 | 2,893.542 | 2,667.002 | 2,261.434 | 1,899.283 | 1,582.828 | 1,199.552 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 432.962 | 277.356 | 550.875 | 452.328 | 682.057 | 502.013 | 365.993 | 443.528 | 479.514 | 515.585 | 392.638 | 276.142 | 163.605 |
| Short Term Debt
| 1,054.809 | 1,048.091 | 922.938 | 959.137 | 698.499 | 576.425 | 322.733 | 486.088 | 430.448 | 201.843 | 196.118 | 171.156 | 81.647 |
| Tax Payables
| 9.473 | 2.805 | 8.874 | 25.311 | 24.392 | 5.245 | 29.496 | 21.859 | 17.295 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 9.473 | 8.711 | 429.178 | 318.573 | 299.116 | 282.465 | 309.128 | 25.459 | 376.136 | 13.769 | 2.141 | 2.92 | 0.55 |
| Other Current Liabilities
| 1,127.225 | 830.376 | 63.644 | 0 | 16.528 | 0 | 0 | 341.867 | -0 | 432.138 | 459.969 | 530.94 | 474.599 |
| Total Current Liabilities
| 2,624.469 | 2,164.534 | 1,966.635 | 1,730.038 | 1,696.2 | 1,360.904 | 997.854 | 1,296.942 | 1,286.098 | 1,163.335 | 1,050.866 | 981.158 | 720.401 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 48.65 | 4.032 | 6.648 | 6.528 | 2.996 | 5.046 | 3.101 | 200.671 | 150 | 7.467 | 14.18 | 12.242 | 7.738 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 22.218 | -4.112 | -1.703 | -1.32 | -0.868 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 4.868 | 4.112 | 1.703 | 1.32 | 0.868 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 30 | 27.671 | 26.105 | 25.746 | -2.996 | 18.877 | 18.782 | 20.065 | 17.864 | 19.267 | 16.456 | 14.687 | 14.129 |
| Total Non-Current Liabilities
| 78.65 | 31.703 | 32.753 | 32.274 | 27.086 | 23.923 | 21.884 | 220.736 | 167.864 | 26.734 | 30.636 | 26.929 | 21.867 |
| Total Liabilities
| 2,703.119 | 2,196.237 | 1,999.388 | 1,762.312 | 1,723.285 | 1,384.827 | 1,019.737 | 1,517.678 | 1,453.962 | 1,190.069 | 1,081.502 | 1,008.087 | 742.268 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 5,786.598 | 5,282.926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 190.04 | 190.04 | 190.04 | 190.04 | 190.04 | 190.04 | 190.04 | 160.04 | 160.04 | 160.04 | 160.04 | 160.04 | 160.04 |
| Retained Earnings
| 4,414.745 | 4,056.568 | 3,744.735 | 4,456.123 | 3,895.031 | 3,394.667 | 3,011.171 | 1,059.724 | 896.899 | 755.225 | 501.641 | 258.601 | 141.144 |
| Accumulated Other Comprehensive Income/Loss
| 5,909.147 | 150.126 | 149.92 | 151.625 | -180.727 | -177.419 | -169.878 | -163.196 | -155.663 | 126.4 | -138.034 | -127.481 | -119.191 |
| Other Total Stockholders Equity
| -4,414.745 | 1,334.999 | 1,335 | 1,335 | -4,114.771 | -3,614.407 | 1,660.978 | 319.296 | 311.763 | 29.7 | 294.134 | 283.581 | 275.292 |
| Total Shareholders Equity
| 6,099.187 | 5,731.733 | 5,419.695 | 6,132.788 | 5,576.172 | 5,075.807 | 4,692.312 | 1,375.864 | 1,213.04 | 1,071.365 | 817.781 | 574.741 | 457.284 |
| Total Equity
| 6,099.187 | 5,731.536 | 5,419.649 | 6,132.788 | 5,576.172 | 5,075.807 | 4,692.312 | 1,375.864 | 1,213.04 | 1,071.365 | 817.781 | 574.741 | 457.284 |
| Total Liabilities & Shareholders Equity
| 8,802.306 | 7,927.97 | 7,419.083 | 7,895.1 | 7,299.457 | 6,460.634 | 5,712.049 | 2,893.542 | 2,667.002 | 2,261.434 | 1,899.283 | 1,582.828 | 1,199.552 |